Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,700 | 6,499 | 11,992 | 5,253 | 1,275 |
| Other current assets | 0 | 0 | 71 | 87 | 0 |
| TOTAL | $10,812 | $6,566 | $12,148 | $5,413 | $1,912 |
| Non-Current Assets | |||||
| PPE Net | 18 | 56 | 65 | 90 | 115 |
| Other Non-Current Assets | 753 | 0 | 0 | 0 | 15 |
| TOTAL | $771 | $56 | $65 | $90 | $130 |
| Total Assets | $11,583 | $6,622 | $12,213 | $5,503 | $2,042 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 578 | 784 | 1,360 | 554 | 596 |
| Accrued Expenses | 1,398 | 1,130 | 1,153 | 986 | 1,529 |
| Other current liabilities | N/A | N/A | 141 | N/A | N/A |
| TOTAL | $1,998 | $1,914 | $5,565 | $4,451 | $2,142 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 2,911 | 2,911 | N/A |
| Other Non-Current Liabilities | 724 | 0 | 0 | 0 | 0 |
| TOTAL | $724 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,722 | $1,914 | $5,565 | $4,451 | $2,142 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,720 | 75 | 9 | 1 | 15,083 |
| Common Shares | 2 | 0 | 0 | 0 | 0 |
| Retained earnings | -49,419 | -40,506 | -25,467 | -25,347 | -14,517 |
| TOTAL | $8,861 | $4,708 | $6,648 | $1,053 | $-100 |
| Total Liabilities And Equity | $11,583 | $6,622 | $12,213 | $5,504 | $2,042 |